innovation for industry
Toulouse, France, November 18, 2021 - GTP Nano, a contract development and manufacturing organization (CDMO) serving the pharmaceutical industry, announced the production of its first clinical batches at its Toulouse, France plant. A new entrant on the nanodrug market, GTP Nano is leveraging an original partnership with research organization CEA that includes ongoing support with nanoformulation and the development of the associated manufacturing processes, as well as with nanocharacterization.
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.